Blood cancers may blunt vaccine
A significant percentage of people with certain blood-related cancers don’t develop COVID-19 antibodies from vaccinations, leaving them potentially vulnerable to COVID-19 after they get their shots, according to findings by UPMC that were discussed in a virtual news conference Friday. Tests done on 67 fully vaccinated people with “hematologic malignancies” — which include non-solid cancers like leukemia, myeloma and lymphoma — showed 46% didn’t produce COVID-19 antibodies, according to Ghady Haidar, transplant infectious diseases physician. Moreover, of the ...